Shares of Danish pharma Novo Nordisk (NVO +5.8%) surge after it announces FDA approval of its...

|About: Novo Nordisk A/S (NVO)|By:, SA News Editor

Shares of Danish pharma Novo Nordisk (NVO +5.8%) surge after it announces FDA approval of its Levemir drug for pregnant women with diabetes after finding it did not increase the risk to unborn babies. NVO says it's now "the only company that offers a complete portfolio of insulin analogs" with this approval.